Do you want to skip to content? Skip to content
Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
False /oidc-signin/en-gb/ Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))

Search Products by Category

ChloraSolv®

ChloraSolv®

ChloraSolv®  Wound Debridement Gel is a new and unique technology for convenient, effective and gentle wound debridement of patients with hard-to-heal lower leg and diabetic foot ulcers. ChloraSolv®  is based on a unique hypochlorite technology consisting of a two-component system

Discover more

Ordering Information
Code Description Size Quantity
10703 ChloraSolv® Wound Debridement Gel 3 ml 5 per box

The importance of debridement – Introducing a new-Chemo mechanical technology: ChloraSolv®

ChloraSolv® can be used in conjunction with weekly dressings to improve healing of diabetic foot ulcers compared with current standard treatment (advanced wound dressing and sharp debridement)1, effectively eradicating biofilm bacteria in just 2 minutes2

ChloraSolv® can be effective and is well-tolerated in the treatment of hard-to-heal wounds to soften and remove devitalised tissue3, with 72.7% reduction of devitalised tissue and 30.9% wound size reduction after 5 weeks.

ChloraSolv® brings unique benefits for wound debridement

Convenient:

  • Easy to use in primary care settings and in patients’ homes by all healthcare professionals
  • Makes it easy to mechanically remove devitalised tissue, biofilm, pus and dirt by using a blunt instrument and/or washing and wiping off the wound bed4
  • Short application time and fast acting to enable an efficient cleaning procedure3

Effective:

  • Facilitates cleansing and debridement of hard-to-heal wounds4, preserving healthy, viable tissue5
  • Softens the necrotic tissue of hard-to-heal lower leg and diabetic foot ulcers, for gentler and easier wound debridement3,6
  • Contains sodium hypochlorite - a broad-spectrum anti-microbiological agent that reduces the microbiological load2

Gentle:

  • Reduces pain related to debridement in patients with hard-to-heal lower extremities and diabetic foot ulcers3
  • Preserves healthy, granulating and viable tissue during debridement5
  • ChloraSolv® is non-irritant5

 

ChloraSolv® is manufactured by RLS Global AB and exclusively distributed by Convatec. © 2022 RLS Global and Convatec. ChloraSolv® and the RLS logo are trademarks of RLS Global AB. Convatec and the Convatec logo are trademarks of the Convatec group of companies. 

  1. Bergqvist, K., et al. The role of chloramines in treatment of diabetic foot ulcers: an exploratory multi-centre randomised controlled trial, Clinical Diabetes and Endocrinology (2016) 2:6. 
  2. Olausson, S., Ahlenius, M. Fast complete eradication of biofilm by wound debridement gel. EWMA 2021.
  3. Eliasson, B., Fagerdahl, A-M., Jönsson, A., Apelqvist, J. Debriding effect of amino acid-buffered hypochlorite on hard-to-heal wounds covered by devitalised tissue: pilot study. Journal of Wound Care (June 2021) 30:6. 
  4. Instructions For Use
  5. Data on file. RP-00008 Biological Evaluation
  6. Data on file. RP-00087 ChloraSolv Claims Verification

Guides

ChloraSolv Global Leave Behind April 2022

Printable Materials

ChloraSolv JWC Supplement August 2022

ChloraSolv Publication Summary Eliasson April 2022

ChloraSolv Publication Summary Bergqvist

ChloraSolv® Wound Debridement Gel White Paper Infographics

Chlorasolv Wound Debridement Gel White Paper

For more information or to request product samples, get in touch with our team

Contact us

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?